BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 19595077)

  • 1. [PD-1 up-regulation influenced apoptosis of HBV-specific CD8 T cells in patients with acute resolved hepatitis B].
    Xu B; Zhang Z; Shi Y; Chen XY; Wang FS
    Zhonghua Yi Xue Za Zhi; 2009 May; 89(17):1158-61. PubMed ID: 19595077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B.
    Zhang Z; Zhang JY; Wherry EJ; Jin B; Xu B; Zou ZS; Zhang SY; Li BS; Wang HF; Wu H; Lau GK; Fu YX; Wang FS
    Gastroenterology; 2008 Jun; 134(7):1938-49, 1949.e1-3. PubMed ID: 18455515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dynamic expression of PD-1 in HBV-specific cytotoxic T lymphocytes correlates with memory T-cell development in acute hepatitis B patients].
    Gu LL; Xu B; Zhang JY; Zhang Z; Wang FS
    Zhonghua Gan Zang Bing Za Zhi; 2008 Sep; 16(9):649-53. PubMed ID: 18822202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PD-1 upregulation is associated with HBV-specific T cell dysfunction in chronic hepatitis B patients.
    Peng G; Li S; Wu W; Tan X; Chen Y; Chen Z
    Mol Immunol; 2008 Feb; 45(4):963-70. PubMed ID: 17868872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B.
    Fisicaro P; Valdatta C; Massari M; Loggi E; Biasini E; Sacchelli L; Cavallo MC; Silini EM; Andreone P; Missale G; Ferrari C
    Gastroenterology; 2010 Feb; 138(2):682-93, 693.e1-4. PubMed ID: 19800335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic decrease in PD-1 expression correlates with HBV-specific memory CD8 T-cell development in acute self-limited hepatitis B patients.
    Zhang Z; Jin B; Zhang JY; Xu B; Wang H; Shi M; Wherry EJ; Lau GK; Wang FS
    J Hepatol; 2009 Jun; 50(6):1163-73. PubMed ID: 19395117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of intrahepatic HBV-specific cytotoxic T-cells during and after acute HBV infection in humans.
    Sprengers D; van der Molen RG; Kusters JG; De Man RA; Niesters HG; Schalm SW; Janssen HL
    J Hepatol; 2006 Aug; 45(2):182-9. PubMed ID: 16516331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Direct analysis of HBV-specific CD8+ lymphocyte by tetrameric HLA-A2/core 18-27 complex in chronic Hepatitis B].
    Lee CK; Suh JH; Cho YS; Han KH; Chung JB; Chon CY; Moon YM
    Taehan Kan Hakhoe Chi; 2002 Jun; 8(2):139-48. PubMed ID: 12499799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemokine receptor expression of hepatitis B virus-specific CD8+ lymphocyte in chronic B viral infection].
    Lee CK; Suh JH; Cho YS; Han KH; Chung JB; Chon CY; Moon YM
    Taehan Kan Hakhoe Chi; 2002 Dec; 8(4):363-70. PubMed ID: 12506240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection.
    Boni C; Fisicaro P; Valdatta C; Amadei B; Di Vincenzo P; Giuberti T; Laccabue D; Zerbini A; Cavalli A; Missale G; Bertoletti A; Ferrari C
    J Virol; 2007 Apr; 81(8):4215-25. PubMed ID: 17287266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profile of tumor antigen-specific CD8 T cells in patients with hepatitis B virus-related hepatocellular carcinoma.
    Gehring AJ; Ho ZZ; Tan AT; Aung MO; Lee KH; Tan KC; Lim SG; Bertoletti A
    Gastroenterology; 2009 Aug; 137(2):682-90. PubMed ID: 19394336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD8(+) T cells specific for both persistent and non-persistent viruses display distinct differentiation phenotypes but have similar level of PD-1 expression in healthy Chinese individuals.
    He XH; Jia QT; Li FY; Saltis M; Liu Y; Xu LH; Zha QB
    Clin Immunol; 2008 Feb; 126(2):222-34. PubMed ID: 17942371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Research of PD-1 expression in CD8+ T cell of peripheral blood with HBV-associated acute-on-chronic liver failure].
    Liu XY; Shi F; Zhao H; Wang HF
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Apr; 24(2):125-7. PubMed ID: 21110433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imbalanced intrahepatic cytokine expression of interferon-gamma, tumor necrosis factor-alpha, and interleukin-10 in patients with acute-on-chronic liver failure associated with hepatitis B virus infection.
    Zou Z; Li B; Xu D; Zhang Z; Zhao JM; Zhou G; Sun Y; Huang L; Fu J; Yang Y; Jin L; Zhang W; Zhao J; Sun Y; Xin S; Wang FS
    J Clin Gastroenterol; 2009 Feb; 43(2):182-90. PubMed ID: 18633332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restoration of HCV-specific T cell functions by PD-1/PD-L1 blockade in HCV infection: effect of viremia levels and antiviral treatment.
    Urbani S; Amadei B; Tola D; Pedrazzi G; Sacchelli L; Cavallo MC; Orlandini A; Missale G; Ferrari C
    J Hepatol; 2008 Apr; 48(4):548-58. PubMed ID: 18280607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute phase HBV-specific T cell responses associated with HBV persistence after HBV/HCV coinfection.
    Urbani S; Boni C; Amadei B; Fisicaro P; Cerioni S; Valli MA; Missale G; Ferrari C
    Hepatology; 2005 Apr; 41(4):826-31. PubMed ID: 15726541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction.
    Trautmann L; Janbazian L; Chomont N; Said EA; Gimmig S; Bessette B; Boulassel MR; Delwart E; Sepulveda H; Balderas RS; Routy JP; Haddad EK; Sekaly RP
    Nat Med; 2006 Oct; 12(10):1198-202. PubMed ID: 16917489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Association of PD-1 expression on CD4+ CD25 nt/hi CD127 lo regulatory T cells with disease progression in HIV-1 infected patients].
    Cao QH; Xue YL; Wang Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Nov; 25(11):1020-2. PubMed ID: 19900372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PD-1 expression in acute hepatitis C virus (HCV) infection is associated with HCV-specific CD8 exhaustion.
    Urbani S; Amadei B; Tola D; Massari M; Schivazappa S; Missale G; Ferrari C
    J Virol; 2006 Nov; 80(22):11398-403. PubMed ID: 16956940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T cells against HBV, but not HCV.
    Fisicaro P; Valdatta C; Massari M; Loggi E; Ravanetti L; Urbani S; Giuberti T; Cavalli A; Vandelli C; Andreone P; Missale G; Ferrari C
    Gastroenterology; 2012 Dec; 143(6):1576-1585.e4. PubMed ID: 22929808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.